Commerce RI approves incentives for new Amgen biomanufacturing facility

PREPARING FOR SUCCESS: Amgen Rhode Island senior associates Devon Zayas, left, and Scott Lyons conduct a safety check prior to using a bioreactor at the company’s West Greenwich facility. / PBN PHOTO/
RUPERT WHITELEY
PREPARING FOR SUCCESS: Amgen Rhode Island senior associates Devon Zayas, left, and Scott Lyons conduct a safety check prior to using a bioreactor at the company’s West Greenwich facility. / PBN FILE PHOTO/RUPERT WHITELEY
PROVIDENCE – The R.I. Commerce Corp on Tuesday approved approximately $8.2 million in incentives with the possibility for up to $9.4 million in incentives for Immunex Rhode Island Corp., a subsidiary of Amgen Inc., for the construction of an approximately $165 million “next-generation” biomanufacturing facility in West Greenwich. The plant will be built on the current…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display